Search Results - "Lin, Qian‐Meng"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Functional characterization of 27 CYP3A4 variants on macitentan metabolism in vitro by Li, Ying‐hui, Lu, Xiang‐ran, Lin, Qianmeng, Huang, Huan‐le, Liang, Xiao‐long, Cai, Jian‐ping, Cui, Ju, Hu, Guo‐xin

    Published in Journal of pharmacy and pharmacology (01-11-2019)
    “…Objective Macitentan is a new choice for pulmonary hypertension treatment which is converted to active metabolite ACT132577 by human cytochrome P450 3A4. Human…”
    Get full text
    Journal Article
  2. 2

    Effects of 27 CYP3A4 protein variants on saxagliptin metabolism in vitro by liu, Qian, Ou‐Yang, Qiu‐Geng, Lin, QianMeng, Lu, Xiang‐Ran, Ma, Ya‐Qing, Li, Ying‐Hui, Xu, Ren‐Ai, Lin, Dong‐dong, Hu, Guo‐Xin, Cai, Jian‐Ping

    Published in Fundamental & clinical pharmacology (01-02-2022)
    “…Saxagliptin is a dipeptidyl peptidase 4 (DPP‐4) inhibitor widely used in patients with type 2 diabetes. It can increase the amount of insulin after meals and…”
    Get full text
    Journal Article
  3. 3

    Characterization of Genetic Variation in CYP3A4 on the Metabolism of Cabozantinib in Vitro by Lin, Qian-meng, Li, Ying-hui, Lu, Xiang-ran, Wang, Ru, Pang, Ni-hong, Xu, Ren-ai, Cai, Jian-ping, Hu, Guo-xin

    Published in Chemical research in toxicology (19-08-2019)
    “…Cabozantinib is a multityrosine kinase inhibitor and has a wide range of applications in the clinic, whose metabolism is predominately dependent on CYP3A4…”
    Get full text
    Journal Article
  4. 4

    Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro by Li, Ying‐Hui, Lin, QianMeng, Pang, Ni‐Hong, Zhang, Xiao‐Dan, Huang, Huan‐Le, Cai, Jian-Ping, Hu, Guo-Xin

    Published in Basic & clinical pharmacology & toxicology (01-10-2019)
    “…Aim Regorafenib is a tyrosine kinase inhibitor that is mainly metabolized by CYP3A4. The genetic polymorphism of CYP3A4 would contribute to differences in…”
    Get full text
    Journal Article
  5. 5

    Evaluation of the Effects of Apatinib on the Pharmacokinetics of Venlafaxine and O‐desmethylvenlafaxine in SD Male Rats by UPLC–MS/MS by Bao, Su‐su, Wen, Jian, Lin, Qianmeng, Li, Ying‐hui, Huang, Yang‐ge, Zhou, Hong‐yu, Hu, Guo‐xin

    Published in Basic & clinical pharmacology & toxicology (01-12-2018)
    “…The objective of this study was to evaluate the effect of apatinib on the pharmacokinetics of venlafaxine and O‐desmethylvenlafaxine in SD rats and the…”
    Get full text
    Journal Article
  6. 6

    Functional characteristics of CYP3A4 allelic variants on the metabolism of loperamide in vitro by Lin, Qian-Meng, Li, Ying-Hui, Liu, Qian, Pang, Ni-Hong, Xu, Ren-Ai, Cai, Jian-Ping, Hu, Guo-Xin

    Published in Infection and drug resistance (01-01-2019)
    “…Cytochrome P450 3A4 (CYP3A4) appears to be genetically polymorphic, which in turn contributes to interindividual variability in response to therapeutic drugs…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes by Lou, Dan, Bao, Su-su, Li, Ying-hui, Lin, Qian-meng, Yang, Su-fen, He, Jia-yang

    “…Background and Objectives Myricetin is a flavonoid compound that is abundant in teas, red wine, berries, herbs and vegetables with a variety of pharmacological…”
    Get full text
    Journal Article
  9. 9

    Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS by Lin, Qian-meng, Pang, Ni-hong, Li, Ying-hui, Huang, Huan-le, Zhang, Xiao-dan, Hu, Guo-xin, Wang, Zeng-shou

    Published in Chemico-biological interactions (01-09-2019)
    “…The epidemic of loperamide abuse and misuse in the patients for the alternative to opioids has become an increasing worldwide concern and has led to…”
    Get full text
    Journal Article
  10. 10

    Investigation of the Inhibitory Effect of Simvastatin on the Metabolism of Lidocaine Both in vitro and in vivo by Wang, Ying, Ou-Yang, Qiu-Geng, Huang, Wan-Li, Huang, Huan-le, Zhuang, Xin-Lei, Lin, Qian-Meng, Zeng, Da-Li

    Published in Drug design, development and therapy (01-01-2020)
    “…Lidocaine has cardiovascular and neurologic toxicity, which is dose-dependent. Due to CYP3A4-involved metabolism, lidocaine may be prone to drug-drug…”
    Get full text
    Journal Article
  11. 11

    Functional characteristics of CYP3A4 allelic variants on the metabolism of loperamide in vitro This article was published in the following Dove Press journal: Infection and Drug Resistance by Lin, Qian-Meng, Li, Ying-Hui, Liu, Qian, Pang, Ni-Hong, Xu, Ren-Ai, Cai, Jian-Ping, Hu, Guo-Xin

    Published in Infection and drug resistance (01-09-2019)
    “…Background: Cytochrome P450 3A4 (CYP3A4) appears to be genetically polymorphic, which in turn contributes to interindividual variability in response to…”
    Get full text
    Journal Article
  12. 12

    A simple method for solving unidirectional methane gas flow in coal seam based on similarity solution by Zhou, Yan, Meng, Qian, Lin, Baiquan, Qin, Jilong, Zhou, Guiping

    “…The equation used to model the unidirectional flow of methane gas in coal seams is usually formulated as a nonlinear partial differential equation,which needs…”
    Get full text
    Journal Article
  13. 13

    New Research Progress of the Novel Target Drugs for the Treatment of Type 2 Diabetes Mellitus by Pengxiang ZHANG, Lin ZENG, Lu MENG, Qian HUANG, Gaoxiang WANG, Deliang LIU

    Published in Zhongguo quanke yixue (01-07-2022)
    “…At present, there are many types of drugs for clinical treatment of type 2 diabetes mellitus (T2DM) , there are differences in the hypoglycemic mechanisms and…”
    Get full text
    Journal Article